(68)Gallium-PET ((68)Ga-PET) agents have significant clinical promise. The radionuclide can be produced from a (68)Ge/(68)Ga generator on site and is a convenient alternative to cyclotron-based PET isotopes. The short half-life of (68)Ga permits imaging applications with sufficient radioactivity while maintaining patient dose to an acceptable level. Furthermore, due to superior resolution, (68)Ga-PET agents have the ability to replace current SPECT agents in many applications. This article outlines the upcoming agents and challenges faced during the translational development of (68)Ga agents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.apradiso.2012.10.014 | DOI Listing |
Publication Analysis
Top Keywords
68ga-pet agents
8
agents
5
untapped potential
4
potential gallium
4
gallium 68-pet
4
68-pet wave
4
wave ⁶⁸ga-agents
4
⁶⁸ga-agents 68gallium-pet
4
68gallium-pet 68ga-pet
4
agents clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!